NEW YORK (GenomeWeb News) – Investigators at the BC Cancer Agency in British Columbia have reeled in an infusion of C$10 million (US$9.5 million) in funding from regional and national partners to fund an effort to use genome sequencing to personalize treatments for patients with lymphoid cancers.

The project at the BC Cancer Agency's Centre for Lymphoid Cancer was funded by Genome BC, the BC Cancer Foundation, Genome Canada, and the Canadian Institute of Health Research, Genome BC said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.